4.6 Article

S100A9 a new marker for monocytic human myeloid-derived suppressor cells

期刊

IMMUNOLOGY
卷 136, 期 2, 页码 176-183

出版社

WILEY-BLACKWELL
DOI: 10.1111/j.1365-2567.2012.03566.x

关键词

cancer; flow cytometry; FACS; immune response; tolerance; tumour immunology

资金

  1. National institutes of Health, National Cancer Institute, Center for Cancer Research
  2. Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer

向作者/读者索取更多资源

Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of cells that negatively regulate the immune response during tumour progression, inflammation and infection. Only limited data are available on human MDSC because of the lack of specific markers. We have identified members of the S100 protein family S100A8, S100A9 and S100A12 specifically expressed in CD14+ HLA-DR-/low MDSC. S100A9 staining in combination with anti-CD14 could be used to identify MDSC in whole blood from patients with colon cancer. An increase in the population of CD14+ S100A9high MDSC was observed in the peripheral blood from colon cancer patients in comparison with healthy controls. Finally, nitric oxide synthase expression, a hallmark of MDSC, was induced in CD14+ S100A9high upon lipopolysaccharide/interferon-? stimulation. We propose S100 proteins as useful markers for the analysis and further characterization of human MDSC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据